Ehud Geller - 09 Jul 2026 Form 4 Insider Report for REGENTIS BIOMATERIALS LTD. (RGNT)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: RGNT
Reported as of: 09 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 13 Jul 2026, 17:05:32 UTC
Prior SEC filing: 18 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Ehud Geller

Key filing fact

Ehud Geller filed Form 4 for REGENTIS BIOMATERIALS LTD. (RGNT) on 13 Jul 2026.

Key facts

This page summarizes Ehud Geller's Form 4 filing for REGENTIS BIOMATERIALS LTD. (RGNT).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 13 Jul 2026, 17:05.

Change

Previous filing in this sequence was filed on 18 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001284386 Primary reporting owner

GELLER EHUD

Relationship: Chief Executive Officer, Director
Address: C/O REGENTIS BIOMATERIALS LTD., 60 MEDINAT HAYHEHUDIM, HERZLIYA
Signature: /s/ Ehud Geller
Signature date: 13 Jul 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

RGNT transaction Derivative

Warrants to purchase ordinary shares

Award

Transaction value
Shares: +31,250
Change %
Price: $0.000000^*
Shares after: 31,250
Date: 09 Jul 2026
Ownership: Direct
Underlying class: Ordinary Shares
Underlying amount: 31,250
Exercise price: $0.003000
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

This warrant was approved by the Board of Directors of the Issuer on February 23, 2026, subject to shareholder approval, which was obtained on July 9, 2026.

Footnote F2

The warrants are currently exercisable and have a three year term.